Low participation raises concern for cancer clinical trials

Low participation raises concern for cancer clinical trials

So the 58-year-old Akron businessman, whose estrogen-receptor-positive and BRCA 1 breast cancer had spread to his bones, liver and lungs, said it “didn't take much arm-twisting” to convince him to join a clinical trial to test a new treatment. “At that

(Visited 1 times, 1 visits today)
7
Like
Save

Comments

Comments are disabled for this post.